Literature DB >> 27816723

Ossifying fibromyxoid tumor: a study of 6 cases of atypical and malignant variants.

Kossivi Dantey1, Karen Schoedel1, Oleksandr Yergiyev1, Richard McGough2, Alka Palekar1, Uma N M Rao3.   

Abstract

Ossifying fibromyxoid tumors (OFMT) of soft parts are rare, slow-growing tumors that have potential for local recurrence and may metastasize. While OFMT originally was considered benign, several cases of malignant OFMT have been documented. There is no universally accepted risk stratification, although this study emphasizes the importance of utilizing histology, immunohistochemistry and FISH in establishing the diagnosis. Herein, we describe six cases of atypical and malignant OFMT with differences in morphologic features, 5 of which display the proposed morphological criteria for malignancy. The patients were mostly male (M=5, F=1) with an age range of 33-69 years. The tumors arose from the extremities (3 cases), the shoulder (1 case), the head and neck area (1 case), and the paraspinal area (1 case). One tumor had high grade and overtly sarcomatous changes, while another invaded the underlying clavicle. Two cases showed cytological atypia and necrosis. Fluorescence in situ hybridization (FISH) detected rearrangement of the PHF1 gene in 5 cases. All cases were positive for EAAT4 and actin by immunohistochemistry, while negative for desmin. Three tumors were immunoreactive for S100 protein. INI-1 immunohistochemical staining was conserved in all but 2 cases in which a mosaic loss of expression was noted. All but two patients are currently alive and free of disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EEAT4; Fibrosarcoma; Malignant; Ossifying fibromyxoid tumor; PHF1 gene

Mesh:

Substances:

Year:  2016        PMID: 27816723     DOI: 10.1016/j.humpath.2016.10.012

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor.

Authors:  Salvatore Provenzano; Alessandra Raimondi; Rossella M Bertulli; Vittoria Colia; Salvatore L Renne; Paola Collini; Gianpaolo Dagrada; Dario Callegaro; Marco Fiore; Francesca G Greco; Paolo G Casali
Journal:  Clin Sarcoma Res       Date:  2017-12-28

2.  A rare case report of a typical variant ossifying fibromyxoid tumor (OFMT), located in the retroauricular perimastoid region.

Authors:  Theodoros Varakliotis; Gianluca Bellocchi; Alberto Eibenstein; Gilberto Acquaviva; Francesco Casorati
Journal:  Int J Surg Case Rep       Date:  2018-02-14

3.  Malignant ossifying fibromyxoid tumor of the calvaria: illustrative case.

Authors:  Jan T Hachmann; R Scott Graham
Journal:  J Neurosurg Case Lessons       Date:  2021-08-23

4.  Ossifying fibromyxoid tumor of the oral cavity: rare case report and long-term follow-up.

Authors:  Maria Eduarda Pérez-de-Oliveira; Thayná Melo de Lima Morais; Márcio Ajudarte Lopes; Oslei Paes de Almeida; Willie F P van Heerden; Pablo Agustin Vargas
Journal:  Autops Case Rep       Date:  2020-12-08

5.  Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases.

Authors:  Marta Sbaraglia; Elena Bellan; Marco Gambarotti; Alberto Righi; Lucia Zanatta; Luisa Toffolatti; Angelo P Dei Tos
Journal:  Pathologica       Date:  2020-11-03

Review 6.  Ossifying Fibromyxoid tumor of soft parts in head and neck: case report and literature review.

Authors:  Ignacio A Velasco; Ran Zhang; Tiejun Li; Diancan Wang
Journal:  Diagn Pathol       Date:  2018-03-27       Impact factor: 2.644

7.  Ossifying fibromyxoid tumor of soft tissue: A case report with review of literature.

Authors:  Ahlem Bchir; Ahlem Bellalah; Nouha Ben Abdeljelil; Manel Njima; Leila Njim; Abdelfateh Zakhama; Rym Hadhri
Journal:  Ann Med Surg (Lond)       Date:  2021-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.